Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.


Journal

Life science alliance
ISSN: 2575-1077
Titre abrégé: Life Sci Alliance
Pays: United States
ID NLM: 101728869

Informations de publication

Date de publication:
01 08 2022
Historique:
received: 20 08 2021
revised: 04 07 2022
accepted: 06 07 2022
entrez: 1 8 2022
pubmed: 2 8 2022
medline: 4 8 2022
Statut: epublish

Résumé

Down syndrome (DS) is caused by human chromosome 21 (HSA21) trisomy. It is characterized by a poorly understood intellectual disability (ID). We studied two mouse models of DS, one with an extra copy of the <i>Dyrk1A</i> gene (189N3) and the other with an extra copy of the mouse Chr16 syntenic region (Dp(16)1Yey). RNA-seq analysis of the transcripts deregulated in the embryonic hippocampus revealed an enrichment in genes associated with chromatin for the 189N3 model, and synapses for the Dp(16)1Yey model. A large-scale yeast two-hybrid screen (82 different screens, including 72 HSA21 baits and 10 rebounds) of a human brain library containing at least 10<sup>7</sup> independent fragments identified 1,949 novel protein-protein interactions. The direct interactors of HSA21 baits and rebounds were significantly enriched in ID-related genes (<i>P</i>-value < 2.29 × 10<sup>-8</sup>). Proximity ligation assays showed that some of the proteins encoded by HSA21 were located at the dendritic spine postsynaptic density, in a protein network at the dendritic spine postsynapse. We located HSA21 DYRK1A and DSCAM, mutations of which increase the risk of autism spectrum disorder (ASD) 20-fold, in this postsynaptic network. We found that an intracellular domain of DSCAM bound either DLGs, which are multimeric scaffolds comprising receptors, ion channels and associated signaling proteins, or DYRK1A. The DYRK1A-DSCAM interaction domain is conserved in <i>Drosophila</i> and humans. The postsynaptic network was found to be enriched in proteins associated with ARC-related synaptic plasticity, ASD, and late-onset Alzheimer's disease. These results highlight links between DS and brain diseases with a complex genetic basis.

Identifiants

pubmed: 35914814
pii: 5/12/e202101205
doi: 10.26508/lsa.202101205
pmc: PMC9348576
pii:
doi:

Banques de données

GENBANK
['IM-27626']

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIA NIH HHS
ID : P30 AG066507
Pays : United States

Informations de copyright

© 2022 Viard et al.

Références

J Neurosci. 2013 Feb 27;33(9):4055-65
pubmed: 23447614
Nat Rev Neurosci. 2009 Jul;10(7):475-80
pubmed: 19543219
Nat Protoc. 2012 Mar 01;7(3):562-78
pubmed: 22383036
PLoS Genet. 2011 Jan 13;7(1):e1001273
pubmed: 21249183
J Neurosci. 2014 Aug 27;34(35):11641-51
pubmed: 25164660
Neuron. 2014 Jul 2;83(1):11-26
pubmed: 24991952
Cold Spring Harb Symp Quant Biol. 2018;83:45-56
pubmed: 30886054
Cell Rep. 2017 Oct 17;21(3):679-691
pubmed: 29045836
Nat Genet. 2021 Jun;53(6):817-829
pubmed: 34002096
Sci Signal. 2016 Aug 09;9(440):rs8
pubmed: 27507650
Nat Rev Neurosci. 2015 Sep;16(9):564-74
pubmed: 26243569
J Neurosci. 2018 Feb 7;38(6):1493-1510
pubmed: 29311144
Nat Neurosci. 2013 Jan;16(1):16-24
pubmed: 23201973
Hum Mol Genet. 2010 Jul 15;19(14):2841-57
pubmed: 20457675
Angew Chem Int Ed Engl. 2014 Nov 17;53(47):12696-717
pubmed: 25339369
Cell. 1996 Jul 12;86(1):59-69
pubmed: 8689688
Nat Genet. 2013 Dec;45(12):1452-8
pubmed: 24162737
Nat Rev Genet. 2017 Mar;18(3):147-163
pubmed: 28029161
PLoS One. 2010 Apr 21;5(4):e10292
pubmed: 20422020
Neurobiol Dis. 2012 Apr;46(1):190-203
pubmed: 22293606
Am J Hum Genet. 2004 Mar;74(3):552-7
pubmed: 14963808
Mol Psychiatry. 2020 Sep;25(9):2000-2016
pubmed: 30967682
Proc Natl Acad Sci U S A. 2012 Feb 14;109(7):2642-7
pubmed: 22308328
Neuron. 2004 Jun 24;42(6):947-59
pubmed: 15207239
Nat Methods. 2006 Dec;3(12):995-1000
pubmed: 17072308
Genome Res. 2005 Mar;15(3):376-84
pubmed: 15710747
Nat Rev Genet. 2004 Oct;5(10):725-38
pubmed: 15510164
Nucleic Acids Res. 2019 Jul 2;47(W1):W199-W205
pubmed: 31114916
Trends Neurosci. 2008 Aug;31(8):419-27
pubmed: 18597863
Neuron. 2019 Jul 17;103(2):217-234.e4
pubmed: 31171447
Nature. 2022 Apr;604(7906):502-508
pubmed: 35396580
Trends Neurosci. 2009 Apr;32(4):199-206
pubmed: 19268374
Nat Rev Neurosci. 2012 Dec;13(12):844-58
pubmed: 23165261
Nat Rev Neurosci. 2004 Oct;5(10):771-81
pubmed: 15378037
Science. 2003 Nov 21;302(5649):1368-73
pubmed: 14576440
Dis Model Mech. 2018 Jun 12;11(6):
pubmed: 29716957
J Neurosci. 2013 Jul 31;33(31):12586-98
pubmed: 23904596
Adv Exp Med Biol. 2012;970:81-95
pubmed: 22351052
Elife. 2018 Feb 27;7:
pubmed: 29485402
Nature. 2014 Jul 17;511(7509):344-7
pubmed: 24896178
Proc Natl Acad Sci U S A. 2011 Mar 15;108(11):4447-52
pubmed: 21368174
Proc Natl Acad Sci U S A. 2017 May 23;114(21):5533-5538
pubmed: 28484035
J Neurosci. 2012 Nov 21;32(47):16637-50
pubmed: 23175819
Genes (Basel). 2021 Nov 20;12(11):
pubmed: 34828439
J Neurosci. 2019 Nov 20;39(47):9306-9315
pubmed: 31597723
Proc Natl Acad Sci U S A. 1997 Feb 4;94(3):1007-12
pubmed: 9023373
Nat Rev Dis Primers. 2020 Feb 6;6(1):9
pubmed: 32029743
Nat Neurosci. 2018 May;21(5):671-682
pubmed: 29686261
Neuron. 2013 Oct 16;80(2):292-311
pubmed: 24139035
J Cell Biol. 1997 Feb 10;136(3):669-78
pubmed: 9024696
Nat Genet. 1997 May;16(1):28-36
pubmed: 9140392
Hum Mol Genet. 2009 Apr 15;18(8):1405-14
pubmed: 19218269
Neuron. 2015 Sep 23;87(6):1215-1233
pubmed: 26402605
Science. 2009 Jan 23;323(5913):474-7
pubmed: 19164740
Cold Spring Harb Perspect Biol. 2011 Dec 01;3(12):
pubmed: 22046028
Nat Rev Dis Primers. 2021 Jun 17;7(1):42
pubmed: 34140529
Methods Enzymol. 2002;350:513-24
pubmed: 12073333
Nature. 2015 Mar 12;519(7542):223-8
pubmed: 25533962
Cell Rep. 2021 Oct 19;37(3):109828
pubmed: 34686348
Nat Commun. 2013;4:2136
pubmed: 23868368
Exp Cell Res. 2010 Feb 15;316(4):667-75
pubmed: 19909739
Neuron. 2012 Oct 4;76(1):223-39
pubmed: 23040817
J Neurosci. 2014 Jan 22;34(4):1138-47
pubmed: 24453307
J Neurosci. 2012 Jul 4;32(27):9217-27
pubmed: 22764230
Cell. 2018 Jul 26;174(3):505-520
pubmed: 30053424
DNA Res. 2002 Jun 30;9(3):89-97
pubmed: 12168953
Nature. 2016 Aug 11;536(7615):210-4
pubmed: 27462810
Nat Genet. 2019 Mar;51(3):414-430
pubmed: 30820047
Annu Rev Biophys. 2013;42:217-39
pubmed: 23654304
Curr Biol. 2007 Oct 23;17(20):1752-8
pubmed: 17935993
Nat Neurosci. 2017 Aug;20(8):1150-1161
pubmed: 28671696
Neuron. 2013 Feb 6;77(3):542-58
pubmed: 23395379
Hum Mol Genet. 2007 Jun 1;16(11):1359-66
pubmed: 17412756
Cell Rep. 2013 Apr 25;3(4):1306-20
pubmed: 23602568
EMBO Mol Med. 2009 Apr;1(1):6-9
pubmed: 20049698
Lancet Neurol. 2016 May;15(6):622-36
pubmed: 27302127
Nat Genet. 1997 Jul;16(3):277-82
pubmed: 9207794
Cell. 2020 Feb 6;180(3):568-584.e23
pubmed: 31981491
Neuron. 2001 Aug 2;31(2):289-303
pubmed: 11502259
J Neurosci. 2011 Aug 31;31(35):12554-65
pubmed: 21880917
Neurobiol Dis. 2006 Jun;22(3):463-72
pubmed: 16455265
Science. 2019 Nov 29;366(6469):1134-1139
pubmed: 31727856

Auteurs

Julia Viard (J)

Centre Psychiatrie and Neurosciences, INSERM U894, Paris, France.
Laboratoire de Génomique Fonctionnelle, CNG, Commissariat à l'Énergie Atomique et aux Énergies Alternatives (CEA), Evry, France.

Yann Loe-Mie (Y)

Centre Psychiatrie and Neurosciences, INSERM U894, Paris, France.

Rachel Daudin (R)

Centre Psychiatrie and Neurosciences, INSERM U894, Paris, France.

Malik Khelfaoui (M)

Centre Psychiatrie and Neurosciences, INSERM U894, Paris, France.

Christine Plancon (C)

Laboratoire de Génomique Fonctionnelle, CNG, Commissariat à l'Énergie Atomique et aux Énergies Alternatives (CEA), Evry, France.

Anne Boland (A)

Laboratoire de Génomique Fonctionnelle, CNG, Commissariat à l'Énergie Atomique et aux Énergies Alternatives (CEA), Evry, France.

Francisco Tejedor (F)

Instituto de Neurociencias, Consejo Superior de Investigaciones Científicas-Universidad Miguel Hernández (CSIC-UMH), Universidad Miguel Hernandez-Campus de San Juan, San Juan, Spain.

Richard L Huganir (RL)

Department of Neuroscience, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.

Eunjoon Kim (E)

Department of Biological Sciences, Korea Advanced Institute of Science and Technology (KAIST), Center for Synaptic Brain Dysfunctions, Institute for Basic Science (IBS), Daejeon, Republic of Korea.

Makoto Kinoshita (M)

Department of Molecular Biology, Division of Biological Science, Nagoya University Graduate School of Science, Nagoya, Japan.

Guofa Liu (G)

Department of Biological Sciences, University of Toledo, Toledo, OH, USA.

Volker Haucke (V)

Department of Molecular Pharmacology and Cell Biology, Leibniz Institut für Molekulare Pharmakologie (FMP) and Freie Universität Berlin, Berlin, Germany.

Thomas Moncion (T)

Hybrigenics, Paris, France.

Eugene Yu (E)

Department of Cellular and Molecular Biology, Roswell Park Division of Graduate School, State University of New York at Buffalo, Buffalo, NY, USA.

Valérie Hindie (V)

Hybrigenics, Paris, France.

Henri Bléhaut (H)

Institut Jérôme Lejeune, Paris, France.

Clotilde Mircher (C)

Institut Jérôme Lejeune, Paris, France.

Yann Herault (Y)

Institut de Génétique et de Biologie Moléculaire et Cellulaire, Illkirch, France.
Centre National de la Recherche Scientifique (CNRS), UMR7104, Illkirch, France.
INSERM, U964, Illkirch, France.
Université de Strasbourg, Illkirch, France.
PHENOMIN, Institut Clinique de la Souris, ICS, GIE CERBM, CNRS, INSERM, Université de Strasbourg, Illkirch-Graffenstaden, France.

Jean-François Deleuze (JF)

Laboratoire de Génomique Fonctionnelle, CNG, Commissariat à l'Énergie Atomique et aux Énergies Alternatives (CEA), Evry, France.

Jean-Christophe Rain (JC)

Hybrigenics, Paris, France.

Michel Simonneau (M)

Centre Psychiatrie and Neurosciences, INSERM U894, Paris, France michel.simonneau@ens-paris-saclay.fr.
Université Paris-Saclay, CNRS, ENS Paris-Saclay, CentraleSupélec, LuMIn, Gif sur Yvette, France.
Department of Biology, Ecole Normale Supérieure Paris-Saclay Université Paris-Saclay, Gif sur Yvette, France.

Aude-Marie Lepagnol-Bestel (AM)

Centre Psychiatrie and Neurosciences, INSERM U894, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH